Markets
Top Stock Gainers of The Day and A Cure For Cancer?
Friday, March 21, 2014
Source: InsideIndianaBusiness
There were many large-scale gainers in the stock market today despite the fact that Dow Jones, NASDAQ, and S&P 500 all declined. Among the top gainers was Endocyte, Magnegas Corporation, and Unwired Planet, with Endocyte being the top gainer of the day. Endocyte catapulted 92.4 percent for two main reasons.
One being their announcement that their drug, Vynfinit, should be approved as a treatment for ovarian cancer, and the drug lowered the risk of lung cancer worsening or causing death by 25 percent compared to Docetaxel, a well-established chemotherapy medication.
The other is that Endocyte and its partner Merck received a positive review from the Committee for Medicinal Product for Human Use in the European Union, saying that it should be approved to help women suffering from ovarian caner who are unresponsive to platinum-based chemotherapy. Overall, Endocyte made a name for itself reaching an all-time high of $33.70.
Top Gainers:
_________________________________________________________________________________
Top Stock Gainers of The Day and A Cure For Cancer?
Friday, March 21, 2014
|
| Source: InsideIndianaBusiness |
One being their announcement that their drug, Vynfinit, should be approved as a treatment for ovarian cancer, and the drug lowered the risk of lung cancer worsening or causing death by 25 percent compared to Docetaxel, a well-established chemotherapy medication.
The other is that Endocyte and its partner Merck received a positive review from the Committee for Medicinal Product for Human Use in the European Union, saying that it should be approved to help women suffering from ovarian caner who are unresponsive to platinum-based chemotherapy. Overall, Endocyte made a name for itself reaching an all-time high of $33.70.
Top Gainers:
_________________________________________________________________________________
No comments:
Post a Comment